|
| U.S. Brand
Names |
|
| Allergan® Ear Drops; Auralgan®;
Auroto®; Otocalm®
Ear |

|
|
| Generic
Available |
|
|
Yes |

|
|
| Synonyms |
|
|
Benzocaine and Antipyrine |

|
|
| Pharmacological Index |
|
|
Otic Agent, Analgesic; Otic Agent, Cerumenolytic |

|
|
| Use |
|
|
Temporary relief of pain and reduction of swelling associated with acute
congestive and serous otitis media, swimmer's ear, otitis externa; facilitates
ear wax removal |

|
|
| Pregnancy Risk
Factor |
|
|
C |

|
|
| Adverse
Reactions |
|
|
<1%:
Local: Burning, stinging, tenderness
Miscellaneous: Hypersensitivity reactions |

|
|
| Usual Dosage |
|
|
Otic: Fill ear canal; moisten cotton pledget, place in external ear, repeat
every 1-2 hours until pain and congestion is relieved; for ear wax removal
instill drops 3-4 times/day for 2-3 days |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
Information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Patient
Information |
|
|
For the ear |

|
|
| Nursing
Implications |
|
|
Use of otic anesthetics may mask symptoms of a fulminating middle ear
infection (acute otitis media); not intended for prolonged
use |

|
|
| Dosage Forms |
|
|
Solution, otic: Antipyrine 5.4% and benzocaine 1.4% (10 mL, 15
mL) |

|
|
| References |
|
|
Rodriguez LF, Smolik LM, and Zbehlik AJ,
"Benzocaine-Induced Methemoglobinemia: Report of a Severe Reaction and Review of the Literature,"
Ann Pharmacother, 1994, 28(5):643-9.
|

|
|
Copyright © 2007 Drugs Area
|